You are here: Home » International » News » Others
Business Standard

Astrazeneca to begin Phase 1/2 clinical trials of Covid vaccine in Japan

Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate

Topics
AstraZeneca | Coronavirus | Japan

Reuters  |  TOKYO 

AstraZeneca logo. Photo: Twitter
AstraZeneca logo. Photo: Twitter

TOKYO (Reuters) - said on Friday it is beginning Phase 1/2 clinical trials in of its vaccine candidate.

Trials of the vaccine, known as AZD1222, will be conducted at multiple facilities in Japan, targeting 250 subjects, the company said in a release.

The British company is working with Daiichi Sankyo, JCR Pharma and other partners in to make and distribute the vaccine.

 

(Reporting by Rocky Swift and Chris Gallagher in Tokyo; Editing by Tom Hogue)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, September 04 2020. 13:10 IST
RECOMMENDED FOR YOU
.